1st Quarter - Report

ILLUMINA, INC. for ILLUMINA, INC.

Firm
Client
Income
—
Expenses
$380,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

General Discussions related to the Food and Drug Administration's regulation of diagnostics and lab developed test General Discussion related to Medicares payment system for clinical diagnostic laboratory services General discussions related to Multi-Cancer Early Detection technology HR 7085: BIOSECURE Act; all provisions General Discussion related to funding for National Institutes of Health General Discussion related to funding for Centers for Disease Control and Prevention General Discussion related to funding for biosurveillance General Discussions related to the implementation of P.L. 117-167 (HR 4346): Chips and Science Act

LobbyistCovered position, as disclosed
NICOLAS MAGALLANES —
BRIAN CHRISTOPHER TOOHEY —

Contacted: Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 4346 (118th), H.R. 7085 (118th)

Trade (domestic/foreign) TRD

General Discussions related to export control and trade policy General Discussions related to biotechnology and genomics education

LobbyistCovered position, as disclosed
NICOLAS MAGALLANES —
BRIAN CHRISTOPHER TOOHEY —

Contacted: HOUSE OF REPRESENTATIVES; State, Dept of (DOS); SENATE; Defense, Dept of (DOD); Commerce, Dept of (DOC); Executive Office of the President (EOP)

Defense DEF

P.L. 118-31 (H.R. 2670): National Defense Authorization Act for Fiscal Year 2024; provisions related to national security and trade

LobbyistCovered position, as disclosed
NICOLAS MAGALLANES —
BRIAN CHRISTOPHER TOOHEY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2670 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.